The CINs of Polo-Like Kinase 1 in Cancer
Polo-like kinase 1 (PLK1) is overexpressed near ubiquitously across all cancer types and dysregulation of this enzyme is closely tied to increased chromosomal instability and tumor heterogeneity. PLK1 is a mitotic kinase with a critical role in maintaining chromosomal integrity through its function...
Main Authors: | Chelsea E. Cunningham, Mackenzie J. MacAuley, Frederick S. Vizeacoumar, Omar Abuhussein, Andrew Freywald, Franco J. Vizeacoumar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/10/2953 |
Similar Items
-
Synthetic Genetic Targeting of Genome Instability in Cancer
by: Kirk J. McManus, et al.
Published: (2013-06-01) -
Computational Approaches to Identify Genetic Interactions for Cancer Therapeutics
by: Benstead-Hume Graeme, et al.
Published: (2017-09-01) -
The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?
by: Guillermo de Cárcer
Published: (2019-03-01) -
Humanized yeast genetic interaction mapping predicts synthetic lethal interactions of FBXW7 in breast cancer
by: Morgan W. B. Kirzinger, et al.
Published: (2019-07-01) -
Evolving Therapeutic Strategies to Exploit Chromosome Instability in Cancer
by: Laura L. Thompson, et al.
Published: (2017-11-01)